Literature DB >> 8475412

Interactions of chemotherapy and radiation.

E E Vokes1.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8475412

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  Successful low-dose concurrent chemotherapy and radiation for locally advanced or inoperable non-small cell lung carcinoma: a report of six cases.

Authors:  V Anku
Journal:  J Natl Med Assoc       Date:  2000-03       Impact factor: 1.798

Review 2.  Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region.

Authors:  Amanda Psyrri; George Fountzilas
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 3.  Locally advanced head and neck cancer.

Authors:  M S Kies; C L Bennett; E E Vokes
Journal:  Curr Treat Options Oncol       Date:  2001-02

4.  Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study.

Authors:  E E Vokes; D J Haraf; P C Hoffman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.

Authors:  E E Vokes; D J Haraf; L C Drinkard; P C Hoffman; M K Ferguson; N J Vogelzang; S Watson; N J Lane; H M Golomb
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 6.  Pharmacokinetic drug interactions with anticancer drugs.

Authors:  P M Loadman; M C Bibby
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

7.  [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.

Authors:  Anuradha Soundararajan; Ande Bao; William T Phillips; Ricardo Perez; Beth A Goins
Journal:  Nucl Med Biol       Date:  2009-05-07       Impact factor: 2.408

8.  Essential drugs for cancer chemotherapy. WHO consultation.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.